DFTX - Definium Therapeutics, Inc. Common Shares -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Definium Therapeutics, Inc. Common Shares
IPO Date: April 27, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $5.21B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.31 | 3.99%
Avg Daily Range (30 D): $1.25 | 2.93%
Avg Daily Range (90 D): $1.28 | 3.46%
Institutional Daily Volume
Avg Daily Volume: 2.41M
Avg Daily Volume (30 D): 2.01M
Avg Daily Volume (90 D): 2.3M
Trade Size
Avg Trade Size (Sh.): 179
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 71
Institutional Trades
Total Institutional Trades: 1,150
Avg Institutional Trade: $2.48M
Avg Institutional Trade (30 D): $2.93M
Avg Institutional Trade (90 D): $3.29M
Avg Institutional Trade Volume: .11M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.17M
Avg Closing Trade (30 D): $10.49M
Avg Closing Trade (90 D): $11.42M
Avg Closing Volume: 202.4K
 
News
Sep 15, 2026 @ 2:16 PM
Definium Reports Second Phase III Success in Anxie...
Source: Zacks.Com
Apr 27, 2026 @ 6:38 PM
These 3 Psychedelic Stocks Activated After Trumpâ...
Source: Nathan Reiff
Apr 20, 2026 @ 3:07 PM
Trump Just Fast-Tracked Psychedelic Treatments: 3 ...
Source: Matthew Benjamin
Feb 27, 2026 @ 4:44 PM
Psychedelic Biotechs Push Toward Phase 3: Five Com...
Source: Prnewswire
Financials
  TTM Q1 2026 N/A
Basic EPS $-1.44 $-.71
Diluted EPS $-1.44 $-.71
Revenue $M $M
Gross Profit
Net Income / Loss $-158.99M $-77.1M
Operating Income / Loss $-75.08M $-59.22M
Cost of Revenue
Net Cash Flow $392.75M $4.68M
PE Ratio    
Splits
Aug 29, 2022 1:15